In RAW 264.7 cells, melatonin (700 μM) induced osteoclast apoptosis and suppressed cancer cell‐stimulated RANKL signaling through p38 inhibition [127], while at 800 μM, it attenuated BMP‐2‐induced osteoclastogenesis [126]. The gene discussed is MAPK1; the disease is cancer.